Diabetes drug Invokana under scrutiny

Beerse, Belgium-based Janssen Pharmaceutical’s top-selling diabetes drug Invokana (canagli­flozin) continued to come under scrutiny in April and May with new lawsuits filed, along with questioning from the European Medicines Agency (EMA) about serious potential adverse effects.

read more

JAS acquires Empi Advance ROM line

Effingham, IL-based Joint Active Systems (JAS) reported on May 3 that it has acquired the Empi Advance ROM line of dynamic braces from Empi, a subsidiary of San Diego-based DJO Global. JAS plans to reintroduce the Empi Advance ROM line by July.

read more

Lakers celebrate Vitti, retiring head AT

The Los Angeles Lakers honored retiring head athletic trainer Gary Vitti, MS, ATC, during the first quarter of the Lakers’ April 3 home game against the Boston Celtics. Vitti, who will retire from his full-time role this summer, has been with the Lakers for 32 seasons and is the longest-tenured trainer in…

read more

Tekscan updates SportsAT software

Boston-based Tekscan in February released its SportsAT 2.0 for balance assessments. SportsAT, which includes a built-in balance compass to aid in rehabilitation and track prog­ress, helps lower extremity practitioners quickly quantify gait asymme­tries and evaluate rehabilitation pro­gress, and…

read more

Radius Health drug cuts fracture risk

Waltham, MA-based Radius Health’s investigational drug abaloparatide-SC (subcutaneous) increases bone mineral density in the spine and hip in postmenopausal women with osteoporosis and may reduce their risk of vertebral and nonvertebral fractures, according to research presented April 1 at Endo 2016, the annual meeting of the Endocrine Society, in Boston.

read more

Join

Subscribe For Updates

Stay in the loop with the latest news and updates! Subscribe now to receive exclusive content, special offers, and important announcements straight to your inbox. Don’t miss out – join our community today for all the latest updates delivered directly to you.